Survival of Secondary Central Nervous System Lymphoma Patients in the Rituximab Era

Clin Lymphoma Myeloma Leuk. 2016 Sep;16(9):e123-e127. doi: 10.1016/j.clml.2016.06.009. Epub 2016 Jun 8.
No abstract available

Keywords: Brain and spinal cord; CNS relapse; Cox proportional hazards; Non-Hodgkin lymphoma; SCNSL.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Central Nervous System Neoplasms / mortality*
  • Central Nervous System Neoplasms / secondary*
  • Female
  • Humans
  • Lymphoma / mortality*
  • Lymphoma / pathology*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab / therapeutic use*
  • Survival Analysis
  • Young Adult

Substances

  • Rituximab